Glenmark Pharmaceuticals rose 1% to Rs 1605.80 after the drug maker announced the upcoming launch of zanubrutinib in India, following approval from the Drugs Controller General of India (DCGI).

Of the 22 analysts that have coverage on Hyundai Motor India, 18 of them have a 'Buy' rating, one has a 'Hold' rating, and ...

The Vivo X200 packs a 6.67-inch AMOLED screen, 120Hz refresh rate, and MediaTek Dimensity 9400 chipset. For photography, it ...

Under the newly-signed Memorandum of Understanding (MoU), both companies will co-develop, bid for, and execute Green Hydrogen ...

We have nothing to gain by raising our concerns internationally as our narrative has got entangled with several controversial ...

China has conducted its national college entrance exam, Gaokao 2025, with 13.35 million (133.5 lakh) students appearing ...

The stock price of the passenger cars & utility vehicles company surpassed its previous high of ₹1,968.80, which it recorded ...

According to the International Sericultural Commission, China is the largest producer of silk in the world, followed by India ...

India has shown impressive AI capabilities in battle, as seen during Operation Sindoor. The adoption of artificial ...

Dhanush's Kuberaa has been creating curiosity and expectations as Nagarjuna is in lead role. The film is scheduled to hit the ...

Indian astronaut Shubhanshu Shukla is in the final prep phase for his first space mission aboard the International Space ...

Audi has now launched the 2025 A4 Signature Edition in India at Rs 57.11 lakh (ex-showroom). Here are the details you must ...